FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 393.0
(-0.57%)
INR 393.0
(-0.57%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.82 Billion INR | 197.07% |
| 2022 | 613.38 Million INR | -38.53% |
| 2021 | 997.86 Million INR | -12.27% |
| 2020 | 1.13 Billion INR | 5.72% |
| 2019 | 1.07 Billion INR | -44.38% |
| 2018 | 1.93 Billion INR | 59.11% |
| 2017 | 1.21 Billion INR | 314.91% |
| 2016 | 293.05 Million INR | -13.45% |
| 2015 | 338.6 Million INR | -49.0% |
| 2014 | 663.91 Million INR | 4.67% |
| 2013 | 634.29 Million INR | 33.36% |
| 2012 | 475.62 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 489.38 Million INR | 28.12% |
| 2023 Q3 | 464.23 Million INR | 758.02% |
| 2023 Q4 | 381.97 Million INR | -17.72% |
| 2023 FY | 681.24 Million INR | 11.06% |
| 2023 Q1 | 322.24 Million INR | -23.84% |
| 2023 Q2 | 54.1 Million INR | -83.21% |
| 2022 FY | 613.38 Million INR | -38.53% |
| 2022 Q3 | 115.53 Million INR | -57.57% |
| 2022 Q1 | 291.4 Million INR | -29.58% |
| 2022 Q4 | 423.1 Million INR | 266.22% |
| 2022 Q2 | 272.26 Million INR | -6.57% |
| 2021 Q4 | 413.82 Million INR | 51.81% |
| 2021 Q1 | 492.48 Million INR | 48.29% |
| 2021 FY | 997.86 Million INR | -12.27% |
| 2021 Q2 | 389.37 Million INR | -20.94% |
| 2021 Q3 | 272.59 Million INR | -29.99% |
| 2020 Q4 | 332.11 Million INR | -45.78% |
| 2020 Q3 | 612.48 Million INR | -6.91% |
| 2020 Q2 | 657.94 Million INR | 5.97% |
| 2020 FY | 1.13 Billion INR | 5.72% |
| 2020 Q1 | 620.89 Million INR | 86.07% |
| 2019 Q2 | 598.98 Million INR | -2.42% |
| 2019 Q4 | 333.68 Million INR | -32.55% |
| 2019 Q1 | 613.81 Million INR | -5.27% |
| 2019 Q3 | 494.68 Million INR | -17.41% |
| 2019 FY | 1.07 Billion INR | -44.38% |
| 2018 Q2 | 900.72 Million INR | 50.64% |
| 2018 FY | 1.93 Billion INR | 59.11% |
| 2018 Q4 | 647.97 Million INR | -27.96% |
| 2018 Q3 | 899.46 Million INR | -0.14% |
| 2018 Q1 | 597.91 Million INR | -14.79% |
| 2017 Q3 | 766.92 Million INR | 65.59% |
| 2017 Q4 | 701.67 Million INR | -8.51% |
| 2017 Q2 | 463.15 Million INR | 103.47% |
| 2017 FY | 1.21 Billion INR | 314.91% |
| 2017 Q1 | 227.63 Million INR | 5.88% |
| 2016 FY | 293.05 Million INR | -13.45% |
| 2016 Q1 | 253.99 Million INR | -0.59% |
| 2016 Q2 | 239.69 Million INR | -5.63% |
| 2016 Q3 | 202.4 Million INR | -15.56% |
| 2016 Q4 | 214.99 Million INR | 6.22% |
| 2015 Q2 | 227.45 Million INR | 3.38% |
| 2015 Q4 | 255.51 Million INR | 22.28% |
| 2015 Q3 | 208.94 Million INR | -8.14% |
| 2015 FY | 338.6 Million INR | -49.0% |
| 2015 Q1 | 220.02 Million INR | 98.54% |
| 2014 Q3 | 146.29 Million INR | -30.44% |
| 2014 Q1 | 196.39 Million INR | 168.23% |
| 2014 FY | 663.91 Million INR | 4.67% |
| 2014 Q2 | 210.29 Million INR | 7.08% |
| 2014 Q4 | 110.82 Million INR | -24.25% |
| 2013 Q2 | 151.06 Million INR | -8.26% |
| 2013 Q4 | 73.21 Million INR | -70.16% |
| 2013 Q3 | 245.33 Million INR | 62.4% |
| 2013 Q1 | 164.67 Million INR | 541.71% |
| 2013 FY | 634.29 Million INR | 33.36% |
| 2012 FY | 475.62 Million INR | 0.0% |
| 2012 Q4 | -37.28 Million INR | -126.4% |
| 2012 Q3 | 141.24 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.46 Million INR | -17318.555% |
| Biocon Limited | 91.73 Billion INR | 98.014% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | 42.322% |
| Concord Biotech Limited | 6.11 Billion INR | 70.183% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 62.842% |
| GENOMIC VALLEY BIOTECH LIMITED | 1.65 Million INR | -110283.462% |
| Lyka Labs Limited | 145.95 Million INR | -1148.462% |
| Panacea Biotec Limited | 1.35 Billion INR | -34.448% |
| SAMSRITA LABS LIMITED | -1.28 Million INR | 142115.245% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 329.57 Million INR | -452.879% |
| Supriya Lifescience Limited | 2.65 Billion INR | 31.286% |
| Syngene International Limited | 12.43 Billion INR | 85.35% |
| TAKE Solutions Limited | 183.42 Million INR | -893.433% |
| Titan Biotech Limited | 884.66 Million INR | -105.972% |
| Transgene Biotek Limited | -1.69 Million INR | 107792.376% |
| Vanta Bioscience Limited | 7.12 Million INR | -25492.065% |